Surgicel 2083 – SNoW® Hemostat, 4″ x 4″
$685.00
Surgicel 2083 – SNoW® Hemostat, 4″ x 4″.
SURGICEL Absorbable Hemostat (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective. SURGICEL SNoW Absorbable Hemostat can be cut to sixe for use in endoscopic procedures.
Description
Surgicel 2083 – SNoW® Hemostat, 4″ x 4″
-Size: 4in x 4in
-Bleeding Situation: Continuous Oozing
-Absorption Time: 7-14 days
-Storage Requirements: Store at controlled room temperature 59º-86ºF (15º-30ºC)
-Preparation Time: Ready out of package
-Shelf Life: 2 Years
-Material/Composition: Oxidized Regenerated Cellulose
More About Surgicel 2083 – SNoW® Hemostat, 4″ x 4″
Additional Specifications
Description
Structured non-woven fabric, needle punched with interlocking fibers
Brand
SURGICEL SNoW®
Size
4in x 4in
Bleeding Situation
Continuous Oozing
Hemostatic Agent & Accessory
Hemostatic Agent
Absorption Time
7-14 days
Storage Requirements
Store at controlled room temperature 59º-86ºF (15º-30ºC)
Preparation Time
Ready out of package
Shelf Life
2 Years
Material/Composition
Oxidized Regenerated Cellulose
NDC/DISTRIBUTOR CODE
63713-0020-83
Category
Adjunctive Hemostasis
QTY/BX
10
Indication
SURGICEL Absorbable Hemostat (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective. SURGICEL SNoW Absorbable Hemostat can be cut to sixe for use in endoscopic procedures.
MOA
Provides a matrix for platelet adhesion and aggregation
https://www.ethicon.com/na/epc/code/2083?lang=en-default
https://www.jnjmedtech.com/en-US/product/surgicel-original-absorbable-hemostat
Additional information
| Amount | Box of 10 |
|---|
Be the first to review “Surgicel 2083 – SNoW® Hemostat, 4″ x 4″”
Reviews
There are no reviews yet.